Medication info
Danellia M Extended-release Tablets 20/1000 mg

Danellia M Extended-release Tablets 20/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›26mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Korea HuTex Pharmaceutical Co., Ltd.
Appearance
Pink oval extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201306 · Approved 2022.04.04 · Insurance code 649105450

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medication should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medication is generally administered once daily with the evening meal, and the dose is adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medication 20/1000mg extended-release tablets once daily. Patients taking this medication 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medication should provide teneligliptin 20 mg once daily and the patient's existing metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medication, the dose of this medication may be started at the patient's existing doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medication have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Since this may cause changes in glycemic control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, this medication should be swallowed whole and not split, crushed, ground, or chewed.

Ingredients

Manufacturer
Korea HuTex Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication helps patients with type 2 diabetes to manage blood sugar more effectively. Teneligliptin and metformin work together to enhance blood sugar control in conjunction with dietary and exercise regimens. This allows for stable management of blood sugar levels, assisting in diabetes management.

How to take

Adult dose

The dose of this medication should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medication is generally administered once daily with the evening meal, and the dose is adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medication 20/1000mg extended-release tablets once daily. Patients taking this medication 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medication should provide teneligliptin 20 mg once daily and the patient's existing metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medication, the dose of this medication may be started at the patient's existing doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medication have not been specifically evaluated in patients switching to it from other glucose-lowering agents. Since this may cause changes in glycemic control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, this medication should be swallowed whole and not split, crushed, ground, or chewed.

Precautions

This medication is used for the treatment of diabetes and can, very rarely, cause a serious condition called lactic acidosis. Lactic acidosis occurs when there is an excessive accumulation of lactic acid in the body, which can be life-threatening. Additionally, severe hypoglycemia may occur when used in conjunction with insulin or sulfonylureas, necessitating careful monitoring of blood sugar levels. Patients with moderate or severe renal impairment, heart problems, acute infections, or severe trauma should not use this medication. Particularly, it must be discontinued for a period before and after undergoing examinations utilizing iodinated contrast agents, and should be restarted only after confirming normal kidney function. Women who are pregnant or may become pregnant, patients with liver dysfunction, and individuals with severe lung dysfunction or excessive alcohol consumption should not use this medication. This medication poses a risk of hypoglycemia; thus, caution is needed with irregular meals, excessive exercise, or concurrent use of other hypoglycemic agents. Furthermore, rare side effects such as acute pancreatitis may occur; therefore, if abdominal pain or vomiting persist, immediate consultation with a physician is necessary. Regular monitoring of renal and hepatic function tests is required while taking this medication, as it may lower vitamin B12 levels, necessitating monitoring through blood tests. Alcohol consumption can increase the risk of side effects, so it should be avoided during treatment. If symptoms such as blisters or skin abnormalities arise, immediate notification to a physician is required, and in cases of severe joint pain, consultation regarding discontinuation of the medication is necessary. In case of overdose, seek medical attention immediately for appropriate treatment, and if needed, blood dialysis can be performed to remove the medication. Children and the elderly require special attention as the safety and efficacy of this medication have not been thoroughly established in these populations; frequent checks of renal function are essential for older patients. This medication must be kept out of reach of children, and transferring it to other containers should be avoided as it may compromise the quality of the medication.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • pemphigoid
  • acute pancreatitis
  • dizziness
Show 176 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcers
  • gastroesophageal reflux disease
  • diarrhea
  • decreased appetite
  • elevated amylase
  • elevated lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • latent hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • elevated serum potassium levels
  • fatigue
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • shingles
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory infection
  • tremor
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweat
  • diabetic retinopathy
  • visual impairment
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophil count
  • blood sugar abnormalities
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureteral stones
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • biliary obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • dizziness
  • diabetic neuropathy
  • sensory abnormalities
  • nasopharyngitis
  • urticaria
  • hepatic coma
  • sensory impairment
  • decreased sensation
  • tension headache
  • peripheral neuropathy
  • facial paralysis
  • sciatica
  • positional dizziness
  • muscle weakness
  • low back pain
  • limb pain
  • lumbar spinal canal stenosis
  • tendonitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle cramps
  • foot deformity
  • hypertrophic osteoarthropathy
  • bursitis
  • spinal osteoarthritis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • shingles
  • gastroenteritis
  • H1N1 influenza
  • bronchitis
  • chronic sinusitis
  • folliculitis
  • cystitis
  • urinary tract infection
  • pharyngitis
  • streptococcal infection
  • tinea pedis
  • subcutaneous abscess
  • Helicobacter gastritis
  • vomiting
  • chronic gastritis
  • stomatitis
  • esophagitis
  • gastrointestinal motility disorder
  • decreased gastrointestinal motility
  • enteritis
  • toothache
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • increased blood sugar
  • abnormal sputum
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • contusion
  • pressure ulcer
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • angina
  • otalgia
  • iron deficiency anemia
  • food allergy
  • hearing loss
  • endolymphatic hydrops
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. Additionally, it is best to store the medication at room temperature between 1°C and 30°C, avoiding excessively hot or cold places.

Appearance and packaging

Appearance

Pink oval extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.